![]() |
市場調查報告書
商品編碼
1871886
全球高度個人化營養補充品市場:未來預測(至2032年)-依產品類型、個人化方法、劑型、通路、用途、最終用戶和地區進行分析Hyper Personalized Supplementation Market Forecasts to 2032 - Global Analysis By Product Type, Personalization Approach, Dosage Form, Distribution Channel, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的一項研究,全球高度個人化補充劑市場預計到 2025 年價值 13 億美元,到 2032 年達到 23 億美元,在預測期內以 8.5% 的複合年成長率成長。
高度個人化營養補充品是指根據個人獨特的生物學特徵、生活方式和健康數據精確配製的營養或膳食補充劑。這種方法整合了基因標記、微生物組譜、活動量和臨床病史,以最佳化營養攝取和治療效果。與千篇一律的解決方案不同,它強調數據驅動的個人化客製化,旨在解決特定的營養缺乏、目標或疾病。這種調查方法支持積極主動的健康管理,提高療效,並符合營養、預防醫學和運動表現最佳化領域的個人化醫療趨勢。
DTC平台的成長
數位化優先的健康平台正在改變消費者獲取個人化營養補充劑的方式。這些平台根據基因、生活方式和生物特徵數據提供量身定做的營養方案,無需傳統的臨床就診。更友善的用戶介面和人工智慧驅動的建議引擎使個人化營養方案更易於取得和推廣。隨著消費者越來越希望自主掌控自己的健康決策,直接面對消費者的模式正日益受到青睞。
缺乏針對個人化處方的標準化指南
原料來源、劑量客製化和測試通訊協定的差異會導致產品功效不一致。不同地區監管政策的不確定性進一步加劇了新參與企業市場進入的困難。由於缺乏統一的框架,製造商難以檢驗產品聲明,也難以確保不同消費族群對產品的安全性。這種缺乏標準化的現狀會削弱消費者的信任,並降低某些特定族群的產品接受度。
與生物技術和營養基因組學公司合作
與生物技術和營養基因組學公司的策略聯盟正在為高度個人化開闢新的可能性。這些合作使得基因組分析、微生物組分析和代謝譜分析能夠整合到膳食補充劑的設計中。利用先進的生物學數據,企業可以創建針對個人健康指標量身定做的精準配方。此類合作也有助於臨床檢驗和監管合規,進而提升產品的可信度。
來自非專利藥保健品品牌的競爭壓力
由於價格實惠且供應廣泛,非專利藥生產商持續佔據商店空間。其大眾市場吸引力和成熟的分銷網路對小眾個人化產品構成威脅。認知有限或預算緊張的消費者可能會選擇傳統產品而非客製化產品。此外,非專利藥激進的定價策略和促銷宣傳活動也可能削弱消費者對高度個人化解決方案的認知價值。
疫情加速了人們對免疫健康和個人化健康管理的關注,推動了高度個人化營養補充劑的短期成長。然而,供應鏈中斷和臨床試驗能力下降暫時減緩了產品研發。在消費者方面,健康意識的提高和遠距離診斷的普及推動了對客製化解決方案的需求。向遠端醫療和數位營養平台的轉變催生了新的通路和互動模式。
預計在預測期內,植物和草藥萃取物細分市場將佔據最大的市場佔有率。
由於植物和草藥萃取物具有天然來源和廣泛的治療應用,預計在預測期內,其市場佔有率將佔據最大。這些成分因其適應原、抗發炎和抗氧化特性而備受推崇,有助於實現個人化的健康目標。提取技術的進步和可追溯性系統的建立提高了產品品質和消費者信心。此外,文化上的親和性以及對植物來源解決方案日益成長的偏好,正在推動各個年齡層的需求。
預計在預測期內,基於微生物組的個人化治療細分市場將實現最高的複合年成長率。
在腸道健康研究和定序技術的突破性進展的推動下,基於微生物組的個人化客製化領域預計將在預測期內實現最高成長率。根據個人腸道微生物組特徵量身定做的補充劑能夠針對性地改善消化功能、免疫力和心理健康。糞便檢驗試劑盒與人工智慧驅動的微生物組分析相結合,使個人化客製化更加精準且更具規模化。隨著人們對腸-腦軸的科學認知不斷加深,消費者對微生物組調節的興趣也日益濃厚。
預計北美將在預測期內佔據最大的市場佔有率,這得益於其強大的數位健康生態系統和較高的消費者健康意識。該地區先進的醫療保健基礎設施和穿戴式裝置的廣泛應用,使得個人化處方的數據收集更加便捷且有效率。監管部門對營養補充品創新的支持以及電子商務市場的強勁滲透,進一步推動了市場成長。美國和加拿大的主要企業正在投資人工智慧、基因組學和直銷模式,鞏固其區域優勢。
在預測期內,北美預計將實現最高的複合年成長率,這主要得益於可支配收入的成長、都市化的加快以及人們對個性化健康管理日益成長的興趣。中國、印度和韓國等國家正在快速普及數位健康工具和基因檢測服務。政府推行的預防性醫療保健和國內製造業發展舉措,為市場擴張創造了有利條件。當地文化對草藥和均衡飲食的重視,也與個人化保健品的概念相契合。
According to Stratistics MRC, the Global Hyper Personalized Supplementation Market is accounted for $1.3 billion in 2025 and is expected to reach $2.3 billion by 2032 growing at a CAGR of 8.5% during the forecast period. Hyper personalized supplementation is the precision-based formulation of dietary or wellness supplements tailored to an individual's unique biological, lifestyle, and health data. This approach integrates genetic markers, microbiome profiles, activity levels, and clinical history to optimize nutrient intake and therapeutic outcomes. Unlike generic solutions, it emphasizes data-driven customization to address specific deficiencies, goals, or conditions. The methodology supports proactive health management, enhances efficacy, and aligns with personalized medicine trends in nutrition, preventive care, and performance optimization.
Growth in direct-to-consumer health platforms
The rise of digital-first health platforms is transforming how consumer's access personalized supplementation. These platforms offer tailored nutrient plans based on genetic, lifestyle, and biometric data, eliminating the need for traditional clinical visits. Enhanced user interfaces and AI-driven recommendation engines are making personalized nutrition more accessible and scalable. As consumers increasingly seek autonomy over their health decisions, direct-to-consumer models are gaining traction.
Lack of standardized guidelines for personalized formulations
Variability in ingredient sourcing, dosage customization and testing protocols can lead to inconsistent product efficacy. Regulatory ambiguity across regions further complicates market entry for new players. Without harmonized frameworks, manufacturers struggle to validate claims and ensure safety across diverse consumer profiles. This lack of standardization may hinder consumer trust and slow adoption rates in certain demographics.
Collaborations with biotech and nutrigenomics firms
Strategic partnerships with biotech and nutrigenomics companies are unlocking new frontiers in hyper personalization. These collaborations enable the integration of genomic sequencing, microbiome analysis, and metabolic profiling into supplement design. By leveraging advanced biological data, firms can create precision formulations that align with individual health markers. Such alliances also facilitate clinical validation and regulatory compliance, enhancing credibility.
Competitive pressure from generic supplement brands
Generic supplement manufacturers continue to dominate shelf space due to their affordability and widespread availability. Their mass-market appeal and established distribution networks pose a threat to niche personalized offerings. Consumers with limited awareness or budget constraints may opt for conventional products over customized alternatives. Additionally, aggressive pricing strategies and promotional campaigns by generic brands can dilute the perceived value of hyper personalized solutions.
The pandemic catalyzes interest in immune health and personalized wellness, driving short-term growth in hyper personalized supplementation. However, supply chain disruptions and reduced clinical testing capacity temporarily slowed product development. On the consumer side, heightened health consciousness and remote diagnostics boosted demand for tailored solutions. The shift toward telehealth and digital nutrition platforms created new distribution channels and engagement models.
The botanical & herbal extracts segment is expected to be the largest during the forecast period
The botanical & herbal extracts segment is expected to account for the largest market share during the forecast period propelled by, their natural origin and broad therapeutic applications. These ingredients are favored for their adaptogenic, anti-inflammatory, and antioxidant properties, which align with personalized health goals. Advances in extraction technologies and traceability systems have improved product quality and consumer confidence. Additionally, cultural familiarity and growing preference for plant-based solutions are driving demand across age groups.
The microbiome-based personalization segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the microbiome-based personalization segment is predicted to witness the highest growth rate, influenced by, breakthroughs in gut health research and sequencing technologies. Supplements tailored to individual microbiome profiles offer targeted benefits for digestion, immunity, and mental well-being. The integration of stool testing kits and AI-driven microbiome analytics is making personalization more precise and scalable. As scientific understanding of the gut-brain axis deepens, consumer interest in microbiome modulation is surging.
During the forecast period, the North America region is expected to hold the largest market share, fuelled by, robust digital health ecosystem and high consumer awareness. The region's advanced healthcare infrastructure and widespread adoption of wearable devices enable seamless data collection for personalized formulations. Regulatory support for nutraceutical innovation and strong e-commerce penetration further bolster market growth. Leading companies in the U.S. and Canada are investing in AI, genomics, and direct-to-consumer models, reinforcing regional dominance.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by, rising disposable incomes, urbanization, and growing interest in personalized wellness. Countries like China, India, and South Korea are witnessing rapid adoption of digital health tools and genetic testing services. Government initiatives promoting preventive healthcare and local manufacturing are creating fertile ground for market expansion. Cultural emphasis on herbal medicine and dietary balance complements the personalized supplementation narrative.
Key players in the market
Some of the key players in Hyper Personalized Supplementation Market include Baze Labs, Persona Nutrition, Rootine, Nutrigenomix, Viome, DNAfit, Habit (Viome-acquired), Tespo, Elo Health, Sun Genomics, Vitagene, MyDNA, InsideTracker, Thorne HealthTech, and Biohm Health.
In November 2025, Habit announced its entry into Dodger Stadium with a new restaurant concept launching in Spring 2026. The move boosts brand visibility and consumer engagement. Though unrelated to Viome's nutrition platform, it reflects Habit's broader lifestyle positioning.
In July 2025, Viome and Scripps launched a 1,000-patient study for an at-home RNA test to detect colon polyps. The test aims to outperform DNA-based kits in early cancer detection. It marks a milestone in RNA-based preventive diagnostics.
In June 2025, Baze Labs, known for personalized vitamin packs, was acquired and integrated into Nature's Way's portfolio. The move strengthens its biochemical testing-based supplement model. The acquisition supports broader distribution and R&D scaling.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.